121 Seaport Blvd Boston
United States

Tel: 475-230-2596

2022 Best Places to Work
Show jobs for this employer

About Alexion

Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Company Ownership: Public
Stock Symbol: AZN
Stock Exchange: Nasdaq

FacebookInstagramTwitterYouTube Logo

717 articles with Alexion